Generic Name and Formulations:
Formulated bovine type I collagen (2.6%); topical gel.
Taxus Cardium Pharmaceuticals Group
Indications for EXCELLAGEN:
Management of wounds including: partial and full- thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/graft, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns and skin tears) and draining wounds.
Adults and Children:
See literature. Perform debridement or excision prior to application. Apply a thin layer directly to the entire wound surface and edges. May be occluded with non-adherent, gauze and foam dressings; change dressings and reevaluate weekly. If healing is incomplete, gel may be reapplied; max once weekly.
Control excessive exudate, excessive bleeding, acute swelling, and/or infection before starting treatment. Discontinue or remove if infections, chronic inflammation, allergic reaction, excessive redness, pain, swelling occur. Do not freeze or reuse syringes. Avoid exposure to high temperature.
Wound care device.
Local reactions (eg, infections, inflammation, swelling).
Kit—1 (4 pre-filled, single-use [0.5mL] syringes w. applicators)
Neurology Advisor Articles
- Excess Abdominal Obesity Linked to Severe Disability in Multiple Sclerosis
- Change in Dietary Patterns Over 5 Years in Early Multiple Sclerosis
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Poor Functional Outcomes Tied to Depressive Symptoms in Multiple Sclerosis
- Oxidized Low-Density Lipoprotein May Predict Risk for Recurrent Stroke
- Inappropriate Prescribing Protocols in Parkinson Disease
- Physical Activity Decreases Vascular Comorbidities in Multiple Sclerosis
- Review of Factors Impacting Sport-Related Concussion Headaches
- Congress Passes Bill to Fight Opioid Crisis